192 related articles for article (PubMed ID: 30387142)
21. Differentiation of conjunctiva mesenchymal stem cells into secreting islet beta cells on plasma treated electrospun nanofibrous scaffold.
Nadri S; Barati G; Mostafavi H; Esmaeilzadeh A; Enderami SE
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):178-187. PubMed ID: 29241367
[TBL] [Abstract][Full Text] [Related]
22. PCL/PVA nanofibrous scaffold improve insulin-producing cells generation from human induced pluripotent stem cells.
Abazari MF; Soleimanifar F; Nouri Aleagha M; Torabinejad S; Nasiri N; Khamisipour G; Amini Mahabadi J; Mahboudi H; Enderami SE; Saburi E; Hashemi J; Kehtari M
Gene; 2018 Sep; 671():50-57. PubMed ID: 29860065
[TBL] [Abstract][Full Text] [Related]
23. Human insulin secreted from insulinogenic xenograft restores normoglycemia in type 1 diabetic mice without immunosuppression.
Kim J; Park S; Kang HM; Ahn CW; Kwon HC; Song JH; Lee YJ; Lee KH; Yang H; Baek SY; Yoo SH; Kim SH; Kim H
Cell Transplant; 2012; 21(10):2131-47. PubMed ID: 22490341
[TBL] [Abstract][Full Text] [Related]
24. Co-transplantation of mesenchymal stromal cells and cord blood cells in treatment of diabetes.
Xiao N; Zhao X; Luo P; Guo J; Zhao Q; Lu G; Cheng L
Cytotherapy; 2013 Nov; 15(11):1374-84. PubMed ID: 24094489
[TBL] [Abstract][Full Text] [Related]
25. Allogeneic diabetic mesenchymal stem cells transplantation in streptozotocin-induced diabetic rat.
Dong QY; Chen L; Gao GQ; Wang L; Song J; Chen B; Xu YX; Sun L
Clin Invest Med; 2008 Dec; 31(6):E328-37. PubMed ID: 19032902
[TBL] [Abstract][Full Text] [Related]
26. Differentiation of Human Wharton's Jelly Mesenchymal Stem Cells into SOX17 Expressing Cells Using a Wnt/ß-catenin Pathway Agonist on Polylactic Acid/Chitosan Nanocomposite Scaffold.
Hoveizi E; Tavakol SH
Cell J; 2022 Feb; 24(2):55-61. PubMed ID: 35279960
[TBL] [Abstract][Full Text] [Related]
27. Generation of insulin-producing cells from human bone marrow mesenchymal stem cells by genetic manipulation.
Karnieli O; Izhar-Prato Y; Bulvik S; Efrat S
Stem Cells; 2007 Nov; 25(11):2837-44. PubMed ID: 17615265
[TBL] [Abstract][Full Text] [Related]
28. Undifferentiated Wharton's Jelly Mesenchymal Stem Cell Transplantation Induces Insulin-Producing Cell Differentiation and Suppression of T-Cell-Mediated Autoimmunity in Nonobese Diabetic Mice.
Tsai PJ; Wang HS; Lin GJ; Chou SC; Chu TH; Chuan WT; Lu YJ; Weng ZC; Su CH; Hsieh PS; Sytwu HK; Lin CH; Chen TH; Shyu JF
Cell Transplant; 2015; 24(8):1555-70. PubMed ID: 25198179
[TBL] [Abstract][Full Text] [Related]
29. Transplantation of differentiated umbilical cord mesenchymal cells under kidney capsule for control of type I diabetes in rat.
Moshrefi M; Yari N; Nabipour F; Bazrafshani MR; Nematollahi-mahani SN
Tissue Cell; 2015 Aug; 47(4):395-405. PubMed ID: 26025422
[TBL] [Abstract][Full Text] [Related]
30. Three-dimensional poly-(ε-caprolactone) nanofibrous scaffolds directly promote the cardiomyocyte differentiation of murine-induced pluripotent stem cells through Wnt/β-catenin signaling.
Chen Y; Zeng D; Ding L; Li XL; Liu XT; Li WJ; Wei T; Yan S; Xie JH; Wei L; Zheng QS
BMC Cell Biol; 2015 Sep; 16():22. PubMed ID: 26335746
[TBL] [Abstract][Full Text] [Related]
31. Hybrid poly-l-lactic acid/poly(ε-caprolactone) nanofibrous scaffold can improve biochemical and molecular markers of human induced pluripotent stem cell-derived hepatocyte-like cells.
Mobarra N; Soleimani M; Ghayour-Mobarhan M; Safarpour S; Ferns GA; Pakzad R; Pasalar P
J Cell Physiol; 2019 Jul; 234(7):11247-11255. PubMed ID: 30515778
[TBL] [Abstract][Full Text] [Related]
32. Human placenta-derived mesenchymal stem cells and islet-like cell clusters generated from these cells as a novel source for stem cell therapy in diabetes.
Kadam S; Muthyala S; Nair P; Bhonde R
Rev Diabet Stud; 2010; 7(2):168-82. PubMed ID: 21060975
[TBL] [Abstract][Full Text] [Related]
33. Electrospun Nanofibers for Diabetes: Tissue Engineering and Cell-Based Therapies.
Hoveizi E; Tavakol S; Shirian S; Sanamiri K
Curr Stem Cell Res Ther; 2019; 14(2):152-168. PubMed ID: 30338744
[TBL] [Abstract][Full Text] [Related]
34. Immune-Modulatory Changes After Transplantation Therapy of Insulin Producing Cells Derived from Wharton's Jelly Human Umbilical Cord-Mesenchymal Stem Cells in Diabetes Induced Rats.
Hassanin OM; El-Masry TM; Abu-Zahra FA; El-Adawy S; Abdellah AM
Egypt J Immunol; 2019 Jan; 26(1):55-67. PubMed ID: 31332996
[TBL] [Abstract][Full Text] [Related]
35. Tissue-engineered islet-like cell clusters generated from adipose tissue-derived stem cells on three-dimensional electrospun scaffolds can reverse diabetes in an experimental rat model and the role of porosity of scaffolds on cluster differentiation.
Anitha R; Vaikkath D; Shenoy SJ; Nair PD
J Biomed Mater Res A; 2020 Mar; 108(3):749-759. PubMed ID: 31788956
[TBL] [Abstract][Full Text] [Related]
36. Generation of insulin-producing cells from C3H10T1/2 mesenchymal progenitor cells.
Jian RL; Mao LB; Xu Y; Li XF; Wang FP; Luo XG; Zhou H; He HP; Wang N; Zhang TC
Gene; 2015 May; 562(1):107-16. PubMed ID: 25724395
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of the potential of rhTGF- β3 encapsulated P(LLA-CL)/collagen nanofibers for tracheal cartilage regeneration using mesenchymal stems cells derived from Wharton's jelly of human umbilical cord.
Wang J; Sun B; Tian L; He X; Gao Q; Wu T; Ramakrishna S; Zheng J; Mo X
Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):637-645. PubMed ID: 27770937
[TBL] [Abstract][Full Text] [Related]
38. Islet-like clusters derived from mesenchymal stem cells in Wharton's Jelly of the human umbilical cord for transplantation to control type 1 diabetes.
Chao KC; Chao KF; Fu YS; Liu SH
PLoS One; 2008 Jan; 3(1):e1451. PubMed ID: 18197261
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic efficacy and biodistribution of allogeneic mesenchymal stem cells delivered by intrasplenic and intrapancreatic routes in streptozotocin-induced diabetic mice.
Yaochite JN; Caliari-Oliveira C; de Souza LE; Neto LS; Palma PV; Covas DT; Malmegrim KC; Voltarelli JC; Donadi EA
Stem Cell Res Ther; 2015 Mar; 6(1):31. PubMed ID: 25884215
[TBL] [Abstract][Full Text] [Related]
40. Mesenchymal stem cells and differentiated insulin producing cells are new horizons for pancreatic regeneration in type I diabetes mellitus.
Domouky AM; Hegab AS; Al-Shahat A; Raafat N
Int J Biochem Cell Biol; 2017 Jun; 87():77-85. PubMed ID: 28385600
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
